Guardion Health Sciences, Inc. Quarterly Selling and Marketing Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Guardion Health Sciences, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2016 to Q2 2024.
  • Guardion Health Sciences, Inc. Selling and Marketing Expense for the quarter ending June 30, 2024 was $8.09K, a 5.42% increase year-over-year.
  • Guardion Health Sciences, Inc. Selling and Marketing Expense for the twelve months ending June 30, 2024 was $1.47M, a 9.3% decline year-over-year.
  • Guardion Health Sciences, Inc. annual Selling and Marketing Expense for 2023 was $1.7M, a 17.6% decline from 2022.
  • Guardion Health Sciences, Inc. annual Selling and Marketing Expense for 2022 was $2.07M, a 11% decline from 2021.
  • Guardion Health Sciences, Inc. annual Selling and Marketing Expense for 2021 was $2.32M, a 60.3% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.47M $8.09K +$416 +5.42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.47M $362K -$237K -39.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.7M $780K +$293K +60.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $1.41M $319K -$207K -39.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $1.62M $7.67K -$381K -98% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $2M $599K -$70K -10.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $2.07M $486K -$162K -25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $2.23M $526K -$251K -32.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.48M $389K -$52.3K -11.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.54M $669K +$211K +46.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.32M $649K +$373K +136% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 $1.95M $778K +$610K +365% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $1.34M $441K -$78.3K -15.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.42M $458K -$31.1K -6.37% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.45M $275K -$388K -58.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $1.84M $167K -$281K -62.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.12M $519K +$110K +26.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $2.01M $489K +$135K +38.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.87M $664K +$367K +124% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $1.51M $448K +$208K +86.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $1.3M $409K +$30.7K +8.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.27M $354K -$252K -41.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $1.52M $296K -$9.06K -2.97% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $1.53M $240K +$124K +106% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.41M $379K +$277K +273% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $1.13M $606K +$529K +690% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $600K $305K +$210K +221% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-14
Q3 2017 $390K $116K +$30.6K +35.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $359K $102K -$2.94K -2.81% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $362K $76.7K -$26.8K -25.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $389K $95.1K Oct 1, 2016 Dec 31, 2016 10-K 2018-02-27
Q3 2016 $85.9K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $105K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $104K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.